This fund manager's share price could double in the next 5 years

Australian Ethical Investments Limited (ASX:AEF) is growing fast off a small base.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This morning ethically-focused fund manager Australian Ethical Investments Limited (ASX: AEF) reported its financial results for the full year ending June 30, 2017. Below is a summary of the results with comparisons to the prior corresponding period.

  • Net profit after tax of $2.92m, $3m in prior year
  • Underlying profit of $4.235m, up 11% (excluding cost of operational loss)
  • Revenues of $28.3m
  • Expenses of $25.4m
  • Net inflows of $454m, up 42%
  • Funds under management of $2.15b, up 38%
  • Superannuation members of 35,532, up 34%
  • Earnings per share of $2.70
  • Final dividend of $2.10 per share, total dividend $2.60 per share

This was generally another strong year of growth for the Australian equities manager that was only clouded by the disastrous effects of a unit pricing error that cost $1.96 million to fix. Generally where clients have suffered a loss as a result of something like a unit pricing or distribution error they must be put back in the position they would have been in but for the loss.

Whereas a fortuitous gain on reversing an incorrect trade for example may sit with the client or fund manager depending on different factors including whose capital was employed in the error coming about.

As a result of the error the fund manager probably had to hire additional fund accountants, investment administrators, or operational risk staff in order to tighten up reporting processes.

As investors in Commonwealth Bank of Australia (ASX: CBA) are finding out, the failure to follow procedures or compliance monitoring plans can lead to costly remediation bills.

The hopefully one-off unit pricing issues aside this still looks an attractive stock the firm is is coming off a small base with just $2.15 billion under management. It's also growing quickly thanks to more retail investors investing their superannuation balances with the group as it widens its distribution network via social media, marketing and other more traditional channels. Australia's ballooning superannuation pile looking for a home to invest is a powerful tailwind for the business.

Over the year the group also announced that it had won an institutional mandate and it is now Australia's fastest-growing super fund, despite competition from big-hitting rivals that offer lower fees as they are run not for profit.

For Australian Ethical the potential to build sufficient scale to win institutional business offers its next growth leg as institutional money mandates are eye-wateringly large, where single mandates at the big end of town could equal AEF's entire FUM as of today.

The other key business driver is investment performance and the group ticks the boxes on this front as well with its Australian shares fund delivering returns 4.6% above its benchmark over the past five year period. Institutional investors and their consultants will typically look to a five-year track record as a minimum, whereas retail investors are likely to throw more caution to the wind in assessing more subjective factors.

Outlook

I reckon this company and stock has legs and you only need to look at the rise of fund managers like Wilson Asset Management Limited (ASX: WAM) or Magellan Financial Group Ltd (ASX: MFG) to see what's achievable when a business has half-decent investment performance, alongside the sales teams and networks to back it up.

The stock is trading on a frothy trailing multiple due to the unit pricing error, but looking ahead it could produce a year of big growth while retaining a strong long-term outlook.

Shares are up 530% over the past five years and I'm a buyer on any price weakness below today's price of $115, as I expect profits and the share price will double over the next five years.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »